Search Results - "Morris, John C"

Refine Results
  1. 1

    Transforming growth factor-β: A therapeutic target for cancer by Haque, Sulsal, Morris, John C.

    Published in Human vaccines & immunotherapeutics (03-08-2017)
    “…Transforming growth factor-β (TGF-β) regulates cell growth and differentiation, apoptosis, cell motility, extracellular matrix production, angiogenesis, and…”
    Get full text
    Journal Article
  2. 2

    Alzheimer's disease: the challenge of the second century by Holtzman, David M, Morris, John C, Goate, Alison M

    Published in Science translational medicine (06-04-2011)
    “…Alzheimer's disease (AD) was first described a little more than 100 years ago. It is the most common cause of dementia with an estimated prevalence of 30…”
    Get more information
    Journal Article
  3. 3

    Open access series of imaging studies: longitudinal MRI data in nondemented and demented older adults by Marcus, Daniel S, Fotenos, Anthony F, Csernansky, John G, Morris, John C, Buckner, Randy L

    Published in Journal of cognitive neuroscience (01-12-2010)
    “…The Open Access Series of Imaging Studies is a series of neuroimaging data sets that are publicly available for study and analysis. The present MRI data set…”
    Get more information
    Journal Article
  4. 4

    Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease by Musiek, Erik S, Bhimasani, Meghana, Zangrilli, Margaret A, Morris, John C, Holtzman, David M, Ju, Yo-El S

    Published in JAMA neurology (01-05-2018)
    “…Circadian rhythm disturbances occur in symptomatic Alzheimer disease (AD) and have been hypothesized to contribute to disease pathogenesis. However, it is…”
    Get more information
    Journal Article
  5. 5

    Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease by Aschenbrenner, Andrew J, Gordon, Brian A, Benzinger, Tammie L.S, Morris, John C, Hassenstab, Jason J

    Published in Neurology (28-08-2018)
    “…OBJECTIVETo examine the independent and interactive influences of neuroimaging biomarkers on retrospective cognitive decline. METHODSA total of 152 middle-aged…”
    Get full text
    Journal Article
  6. 6

    Interleukin-15 biology and its therapeutic implications in cancer by Steel, Jason C, Waldmann, Thomas A, Morris, John C

    “…Cancer immunotherapy is designed to stimulate the immune system to reject and destroy tumors. Recently, interleukin-15 (IL-15), a member of the four α-helix…”
    Get full text
    Journal Article
  7. 7

    Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells by Morrison, Brian J, Steel, Jason C, Morris, John C

    Published in BMC cancer (26-04-2018)
    “…It has been proposed that cancer establishment, maintenance, and recurrence may be attributed to a unique population of tumor cells termed cancer-initiating…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study by Vos, Stephanie JB, MSc, Xiong, Chengjie, Prof, Visser, Pieter Jelle, MD, Jasielec, Mateusz S, MS, Hassenstab, Jason, PhD, Grant, Elizabeth A, PhD, Cairns, Nigel J, Prof, Morris, John C, Prof, Holtzman, David M, Prof, Fagan, Anne M, Prof

    Published in Lancet neurology (01-10-2013)
    “…Summary Background New research criteria for preclinical Alzheimer's disease have been proposed, which include stages for cognitively normal individuals with…”
    Get full text
    Journal Article
  10. 10

    Assessment of Racial Disparities in Biomarkers for Alzheimer Disease by Morris, John C, Schindler, Suzanne E, McCue, Lena M, Moulder, Krista L, Benzinger, Tammie L S, Cruchaga, Carlos, Fagan, Anne M, Grant, Elizabeth, Gordon, Brian A, Holtzman, David M, Xiong, Chengjie

    Published in JAMA neurology (01-03-2019)
    “…Racial differences in molecular biomarkers for Alzheimer disease may suggest race-dependent biological mechanisms. To ascertain whether there are racial…”
    Get more information
    Journal Article
  11. 11

    Sleep quality and preclinical Alzheimer disease by Ju, Yo-El S, McLeland, Jennifer S, Toedebusch, Cristina D, Xiong, Chengjie, Fagan, Anne M, Duntley, Stephen P, Morris, John C, Holtzman, David M

    Published in JAMA neurology (01-05-2013)
    “…Sleep and circadian problems are very common in Alzheimer disease (AD). Recent animal studies suggest a bidirectional relationship between sleep and β-amyloid…”
    Get more information
    Journal Article
  12. 12

    Loss of Brain Aerobic Glycolysis in Normal Human Aging by Goyal, Manu S., Vlassenko, Andrei G., Blazey, Tyler M., Su, Yi, Couture, Lars E., Durbin, Tony J., Bateman, Randall J., Benzinger, Tammie L.-S., Morris, John C., Raichle, Marcus E.

    Published in Cell metabolism (01-08-2017)
    “…The normal aging human brain experiences global decreases in metabolism, but whether this affects the topography of brain metabolism is unknown. Here we…”
    Get full text
    Journal Article
  13. 13

    Does institutional location matter? The effect of agency type on resource distribution for nonpoint water pollution by Aistrup, Joseph A., Morris, John C.

    Published in Water policy (01-10-2024)
    “…ABSTRACT With the rejuvenated emphasis on nonpoint pollution under the Water Quality Act (WQA) of 1987, states seek ways to address nonpoint pollution sources…”
    Get full text
    Journal Article
  14. 14

    Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury by Suárez-Calvet, Marc, Araque Caballero, Miguel Ángel, Kleinberger, Gernot, Bateman, Randall J, Fagan, Anne M, Morris, John C, Levin, Johannes, Danek, Adrian, Ewers, Michael, Haass, Christian

    Published in Science translational medicine (14-12-2016)
    “…Emerging evidence supports a role for innate immunity and microglia in Alzheimer's disease (AD) pathophysiology. However, no marker related to microglia has…”
    Get more information
    Journal Article
  15. 15

    Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease by Tarawneh, Rawan, D'Angelo, Gina, Crimmins, Dan, Herries, Elizabeth, Griest, Terry, Fagan, Anne M, Zipfel, Gregory J, Ladenson, Jack H, Morris, John C, Holtzman, David M

    Published in JAMA neurology (01-05-2016)
    “…Synaptic loss is an early pathologic substrate of Alzheimer disease (AD). Neurogranin is a postsynaptic neuronal protein that has demonstrated utility as a…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Functional connectivity and graph theory in preclinical Alzheimer's disease by Brier, Matthew R, Thomas, Jewell B, Fagan, Anne M, Hassenstab, Jason, Holtzman, David M, Benzinger, Tammie L, Morris, John C, Ances, Beau M

    Published in Neurobiology of aging (01-04-2014)
    “…Abstract Alzheimer's disease (AD) has a long preclinical phase in which amyloid and tau cerebral pathology accumulate without producing cognitive symptoms…”
    Get full text
    Journal Article
  18. 18

    Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging by Schindler, Suzanne E., Gray, Julia D., Gordon, Brian A., Xiong, Chengjie, Batrla-Utermann, Richard, Quan, Marian, Wahl, Simone, Benzinger, Tammie L.S., Holtzman, David M., Morris, John C., Fagan, Anne M.

    Published in Alzheimer's & dementia (01-11-2018)
    “…Levels of amyloid β peptide 42 (Aβ42), total tau, and phosphorylated tau-181 are well-established cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease,…”
    Get full text
    Journal Article
  19. 19

    Persistent metabolic youth in the aging female brain by Goyal, Manu S., Blazey, Tyler M., Su, Yi, Couture, Lars E., Durbin, Tony J., Bateman, Randall J., Benzinger, Tammie L.-S., Morris, John C., Raichle, Marcus E., Vlassenko, Andrei G.

    “…Sex differences influence brain morphology and physiology during both development and aging. Here we apply a machine learning algorithm to a multiparametric…”
    Get full text
    Journal Article
  20. 20